CXCR-4

CD20

CD20/ CXCR-4

IgA

IgG

IgA/IgG

CD45

COX-2

COX-2/ CD45

(N)

TOTAL SAMPLE

88.2 ± 2.2

58.0 ± 2.4

49.8 ± 2.5

90.9 ± 1.3

68.4 ± 3.7

61.0 ± 4.2

21.8 ± 2.7

60.2 ± 3.1

6.6 ± 1.9

54

(12.3 - 99.0)

(5.9 - 97.6)

(0.0 - 93.6)

(42.1 - 99.1)

(1.12 - 98.7)

(0.0 - 96.9)

(0.0 - 86.4)

(11.2 - 97.2)

(0.0 - 62.7)

GENDER

Male

88.1 ± 3.3

64.4 ± 4.7

56.4 ± 4.5

88.1 ± 2.6

67.9 ± 5.3

59.3 ± 6.9

28.7 ± 4.3

65.2 ± 4.8

12.1 ± 3.5

23

(25.7 - 99.0)

(5.9 - 97.6)

(0.0 - 93.6)

(42.1 - 98.2)

(1.12 - 98.7)

(0.0 - 96.9)

(0.0 - 70.3)

(17.6 - 97.2)

(0.0 - 56.4)

Female

86.3 ± 3.9

58.2 ± 2.7

48.4 ± 3.8

93.1 ± 1.2

68.7 ± 5.2

62.4 ± 5.2

16.7 ± 3.2

57.3 ± 3.9

2.6 ± 2.0

31

(12.4 - 98.8)

(8.3 - 66.6)

(0.0 - 88.0)

(76.3 - 99.1)

(10.2 - 97.8)

(0.0 - 96.4)

(0.0 - 86.4)

(11.2 - 94.3)

(0.0 - 62.7)

p value

0.74

0.23

0.74

0.06

0.92

0.72

0.03

0.21

0.02

RACE

Caucasian

93.0 ± 1.5

62.1 ± 4.0

55.5 ± 3.8

91.2 ± 1.9

73.6 ± 6.1

66.9 ± 6.1

31.3 ± 4.9

58.4 ± 5.5

11.6 ± 4.5

16

(78.3 - 99.0)

(41.5 - 96.6)

(38.7 - 93.6)

(91.5 - 99.1)

(10.2 - 98.7)

(9.4 - 96.9)

(2.3 - 70.3)

(26.2 - 97.2)

(0.0 - 56.4)

African American

85.9 ± 3.4

61.1 ± 3.0

50.7 ± 3.6

92.1 ± 1.2

67.4 ± 4.5

61.0 ± 4.8

18.0 ± 3.2

62.1 ± 3.7

4.0 ± 2.1

36

(12.4 - 98.8)

(21.5 - 97.6)

(0.0 - 88.0)

(70.5 - 98.7)

(19.1 - 97.8)

(0.0 - 95.6)

(0.0 - 86.4)

(11.2 - 97.0)

(0.0 - 62.7)

p value

0.001

0.01

0.035

0.001

0.034

0.001

0.046

0.142

0.197